PeptideStack
5.2kquestions
20kanswers
220users

Would you accept 97.9% on retatrutide from GGPeps without a content assay?

Asked 15 Mar 2024Modified 2.4 years agoViewed 21k times
This question was marked as a duplicate of Would you accept 95.2% on retatrutide from MKM without a content assay?Closed 4 Apr 2024. It remains here because the answers below are specific to how it was asked.
14

Details up front: 97.9% · retatrutide · GGPeps.

This is a planning question. I know what my options are; I do not know how to weigh them.

What I want is the minimum viable version, which I suspect is smaller than what I would design.

What does a sensible plan look like, and what are the decision points?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questionscontent-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

476 questionsvendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questionsretatrutide
retatrutide

An investigational GLP-1, GIP and glucagon receptor tri-agonist, studied in the TRIUMPH programme. Not approved anywhere. Use this tag for…

251 questions
shareeditfollowflag
BN
askedbridget_nyathi12k1515 Mar 2024

No answers yet

This question has not been answered. It has been viewed 21k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.